CELLECT Laboratories is working on a non-invasive technology that could replace the need for pap smears, while still helping people access life-saving screening.
Duchesnay and PeriPharm announce the publication of an article in the Journal of Obstetrics and Gynaecology Canada (JOGC) to raise awareness about access to innovative medications for women’s health in
A new national survey of commissioned by myStoria reveals a reproductive health system marked by persistent knowledge gaps, widespread provider dismissal, and a near-universal failure of school-based sex education.
Explore why women’s health in defence requires intentional system design, from equipment testing to clinical research, and how we can do it.
HorminaCare, a new virtual healthcare platform dedicated exclusively to women’s hormone health, officially launches its mission to close critical gaps in care by offering accessible, science-backed, root-cause treatment for hormonal
Flora Fertility raises a $5 million seed round for its reproductive insurance platform, aiming to expand access to reproductive care.
Coral, the category-defining virtual clinic for midlife women, announced an additional $4 million CAD acceleration round, only one year after its launch.
myStoria closes a $1.625M seed funding round led by Graphite Ventures to expand reproductive health platform.
In an interview with BNN Bloomberg, Rachel Bartholomew discusses how venture capital is eyeing Canada’s $37B femtech opportunity and scaling women’s health.
200+ advocates, researchers, and leaders gather on Parliament Hill to advance a National Framework for women’s health in Canada.
Our website uses cookies to ensure you get the best experience. Learn more about the policy.